- Home
- TENX vs CLDI Comparison
TENX vs CLDI Comparison
Compare TENX & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- CLDI
- Stock Information
- Founded
- TENX 1967
- CLDI 2014
- Country
- TENX United States
- CLDI United States
- Employees
- TENX N/A
- CLDI N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TENX Health Care
- CLDI Health Care
- Exchange
- TENX Nasdaq
- CLDI Nasdaq
- Market Cap
- TENX 21.8M
- CLDI 18.1M
- IPO Year
- TENX N/A
- CLDI N/A
- Fundamental
- Price
- TENX $6.37
- CLDI $0.89
- Analyst Decision
- TENX Strong Buy
- CLDI Strong Buy
- Analyst Count
- TENX 4
- CLDI 3
- Target Price
- TENX $20.67
- CLDI $16.67
- AVG Volume (30 Days)
- TENX 38.7K
- CLDI 1.2M
- Earning Date
- TENX 11-13-2024
- CLDI 03-14-2025
- Dividend Yield
- TENX N/A
- CLDI N/A
- EPS Growth
- TENX N/A
- CLDI N/A
- EPS
- TENX N/A
- CLDI N/A
- Revenue
- TENX N/A
- CLDI N/A
- Revenue This Year
- TENX N/A
- CLDI N/A
- Revenue Next Year
- TENX N/A
- CLDI N/A
- P/E Ratio
- TENX N/A
- CLDI N/A
- Revenue Growth
- TENX N/A
- CLDI N/A
- 52 Week Low
- TENX $2.77
- CLDI $0.73
- 52 Week High
- TENX $21.46
- CLDI $16.80
- Technical
- Relative Strength Index (RSI)
- TENX 57.59
- CLDI 32.62
- Support Level
- TENX $5.92
- CLDI $0.83
- Resistance Level
- TENX $6.65
- CLDI $0.95
- Average True Range (ATR)
- TENX 0.43
- CLDI 0.12
- MACD
- TENX -0.02
- CLDI -0.03
- Stochastic Oscillator
- TENX 56.21
- CLDI 11.29
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.